Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1978 May;63(1):17-23.
doi: 10.1111/j.1476-5381.1978.tb07769.x.

Action of guanethidine on rabbit atrial membranes

Action of guanethidine on rabbit atrial membranes

Y Misu et al. Br J Pharmacol. 1978 May.

Abstract

1 Intracellular potentials were recorded in driven left atria from reserpine-treated rabbits. Guanethidine 2 X 10(-5) M slightly increased Vmax and shortened the total duration (TD) of the action potential (AP) without causing hyperpolarization. For the first 30 min after 4 X 10(-4) M, Vmax increased without hyperpolarization and AP height increased slightly. Thereafter, Vmax and height decreased with a slight and gradual depolarization. This depolarization was irreversible. TD was increased after 15 minutes. Guanethidine 2 X 10(-3) M initially decreased Vmax and height before causing depolarization. 2. Pretreatment with tetrodotoxin (TTX) 1.6 X 10(-7) M prevented or reversed the initial increases in Vmax, height and TD induced by guanethidine (4 X 10(-4) M). 3 TTX 3.1 to 6.2 X 10(-6) M, added 15 or 30 min after guanethidine 4 X 10(-4) M, delayed or prevented depolarization by guanethidine. 4 Ouabain 10(-5) M incubated for 20 and 90 min greatly inhibited Na+, K+-adenosine triphosphatase and K+-phosphatase activities; guanethidine was without effect. 5 Guanethidine probably increases resting sodium permeability after the promotion of increases in sodium permeability during the AP. High doses of the drug decrease sodium permeability during the AP.

PubMed Disclaimer

References

    1. Br J Pharmacol Chemother. 1965 Aug;25(1):171-8 - PubMed
    1. Int J Neuropharmacol. 1965 Feb;4:27-39 - PubMed
    1. Annu Rev Pharmacol. 1965;5:183-212 - PubMed
    1. Nature. 1964 Sep 26;203:1389 - PubMed
    1. J Pharmacol Exp Ther. 1962 Dec;138:360-75 - PubMed

LinkOut - more resources